Infantile Hemangioma

Infantile hemangioma, also known as “strawberry birthmark,” is a type of benign (non-cancerous) tumor that affects the blood vessels in an infant’s skin. It is the most common type of birthmark in infants, affecting approximately 5% of all newborns. They typically appear during the first few weeks of life and grow rapidly during the first six months, reaching their maximum size by one year of age. After that, they tend to shrink in size and fade over time, with most disappearing completely by the time the child reaches five to seven years of age.

There are several types of infantile hemangiomas, each with different characteristics and growth patterns. The following are the most common types:

Superficial hemangiomas: This type of hemangioma affects the blood vessels in the top layer of skin and is usually bright red in color. They are the most common type of infantile hemangioma and typically appear on the face, scalp, chest, and back.
Deep hemangiomas: This type of hemangioma affects the deeper layers of skin and underlying tissues, and is usually blue or purple in color. They tend to be firmer and less compressible than superficial hemangiomas. Deep hemangiomas can occur anywhere on the body, but are most common on the scalp, neck, and trunk.
Segmental hemangiomas: This type of hemangioma is a variation of the superficial type and affects only one side of the body. They are more likely to occur in areas that are supplied by a specific artery, such as the face or arms.
Mixed hemangiomas: This type of hemangioma is a combination of superficial and deep hemangiomas and may appear as both a bright red and blue or purple color.
Proliferating hemangiomas: This type of hemangioma is characterized by rapid growth and can be dangerous if it affects vital organs such as the eyes, mouth, or airway.

Infantile hemangiomas are caused by the overgrowth of blood vessels in the skin. The exact cause is not known, but it is believed to be related to changes in the normal balance of blood vessel formation and destruction that occurs during embryonic development. Other factors that may contribute to the development of infantile hemangiomas include genetics, maternal factors (such as smoking or use of certain medications during pregnancy), and premature birth.

Causes

While the exact cause of infantile hemangiomas is not known, there are several factors that are believed to contribute to their development. Here are possible causes of infantile hemangiomas:

Genetics: There is evidence that infantile hemangiomas can run in families, suggesting that there may be a genetic component to their development.
Maternal factors: Some studies have suggested that maternal factors, such as smoking during pregnancy, use of certain medications, and advanced maternal age, may increase the risk of developing an infantile hemangioma.
Hormonal factors: Hormonal imbalances during pregnancy, such as elevated levels of estrogen or progesterone, have been suggested as a potential cause of infantile hemangiomas.
Immune system dysfunction: Infantile hemangiomas may develop as a result of an abnormal response of the immune system.
Infections: Some infections during pregnancy, such as cytomegalovirus (CMV) or rubella, have been linked to an increased risk of infantile hemangiomas.
Environmental factors: Exposure to certain environmental toxins, such as pesticides, during pregnancy or early childhood may increase the risk of developing an infantile hemangioma.
Nutritional factors: Nutritional deficiencies, such as low levels of vitamin C or iron, during pregnancy or early childhood have been suggested as a potential cause of infantile hemangiomas.
Prematurity: Infants who are born prematurely are at an increased risk of developing an infantile hemangioma.
Low birth weight: Infants who have a low birth weight are also at an increased risk of developing an infantile hemangioma.
Multiple gestation: Infants who are part of a multiple gestation (such as twins or triplets) are at an increased risk of developing an infantile hemangioma.
Placental abnormalities: Abnormalities of the placenta during pregnancy, such as placental insufficiency, have been linked to an increased risk of infantile hemangiomas.
Blood flow abnormalities: Abnormal blood flow in the developing fetus, such as a blood clot or a blood vessel that is compressed, may increase the risk of developing an infantile hemangioma.
Oxygen deprivation: Deprivation of oxygen during pregnancy or delivery, known as perinatal asphyxia, may increase the risk of developing an infantile hemangioma.
Maternal stress: Maternal stress during pregnancy has been suggested as a potential cause of infantile hemangiomas.
Maternal psychological factors: Maternal psychological factors, such as depression or anxiety, have been linked to an increased risk of infantile hemangiomas.
Maternal autoimmune disease: Maternal autoimmune diseases, such as lupus or rheumatoid arthritis, have been linked to an increased risk of infantile hemangiomas.
Maternal infections: Some maternal infections, such as syphilis or toxoplasmosis, have been linked to an increased risk of infantile hemangiomas.
Maternal substance abuse: Substance abuse during pregnancy, such as alcohol or drug abuse, has been linked to an increased risk of infantile hemangiomas.

Symptoms

Here are symptoms of infantile hemangioma:

Red or purple birthmark: The first and most obvious symptom of IH is a red or purple birthmark that appears on the skin of the affected area. This birthmark can be flat or raised and may be small or large.
Rapid growth: Infantile hemangiomas often grow rapidly in the first few months of life, and the size of the birthmark may double or triple in size within a short period of time.
Location: IHs can develop anywhere on the body, but they are most commonly found on the face, scalp, chest, and back.
Shape: IHs can take on various shapes, including oval, circular, or irregular shapes.
Texture: The texture of IHs can vary, ranging from soft and spongy to firm and hard.
Ulceration: In some cases, IHs may develop an ulcer or open sore on the surface of the birthmark, which can be painful and may cause bleeding.
Itching: Some infants with IH may experience itching or discomfort in the affected area.
Pain: Infants with IH may experience pain or tenderness in the affected area.
Impaired vision: IHs located near the eyes or on the eyelids may cause impaired vision or even blindness if left untreated.
Breathing difficulties: IHs located in the throat or near the airways may cause breathing difficulties, especially in infants.
Disfigurement: Large IHs can cause disfigurement and can affect the appearance of the face, neck, or other areas of the body.
Feeding difficulties: Infants with IHs located near the mouth or in the throat may experience feeding difficulties, including difficulty swallowing or breathing while eating.
Hearing difficulties: IHs located near the ears may cause hearing difficulties.
Developmental delays: Infants with IHs may experience developmental delays, including delayed motor or cognitive development.
Stunted growth: Infants with IHs may experience stunted growth or weight loss due to feeding difficulties or other complications related to the birthmark.
Anemia: Infants with IHs may develop anemia due to blood loss from ulceration or other complications.
High blood pressure: Infants with IHs may experience high blood pressure due to increased blood flow to the affected area.
Increased risk of infection: Infants with IHs may be at increased risk of developing infections due to ulceration or other complications.
Psychological distress: Infants with IHs may experience psychological distress, including anxiety, shame, or low self-esteem due to the appearance of the birthmark.

Diagnosis

There are several diagnostic tests and procedures used to diagnose and monitor IH, including:

Physical Examination: This is the first step in diagnosing IH. The doctor will examine the skin for any signs of abnormal growth or discoloration.
Ultrasound: This is a non-invasive imaging test that uses high-frequency sound waves to create images of the inside of the body. It can be used to confirm the diagnosis of IH and to monitor its growth.
Magnetic Resonance Imaging (MRI): This is a type of imaging test that uses a strong magnetic field and radio waves to create detailed images of the body. It can be used to determine the size and location of an IH and to monitor its growth.
Computed Tomography (CT) Scan: This is a type of imaging test that uses X-rays and computer technology to create detailed cross-sectional images of the body. It can be used to determine the size and location of an IH and to monitor its growth.
Biopsy: A biopsy is a procedure in which a small sample of tissue is taken from the IH and examined under a microscope. This can be used to confirm the diagnosis of IH and to rule out other conditions that may look similar.
Dermoscopy: This is a non-invasive diagnostic tool that uses a special magnifying lens to examine the surface of the skin. It can be used to help diagnose IH and to monitor its growth.
Angiography: This is a diagnostic test that uses X-rays and a special dye to visualize the blood vessels in the body. It can be used to determine the location and size of an IH and to monitor its growth.

Treatment

Treatment for infantile hemangiomas depends on the size, location, and depth of the lesion, as well as the age of the child and the presence of any associated medical problems. Here are 20 treatments for infantile hemangiomas:

Observation: For small, superficial hemangiomas, simply observing the lesion without treatment may be the best approach. This is because many hemangiomas shrink and disappear on their own over time.
Topical Corticosteroids: Topical corticosteroids, such as hydrocortisone, can be used to treat superficial hemangiomas. They work by reducing inflammation and helping the lesion shrink.
Systemic Corticosteroids: Systemic corticosteroids, such as prednisone, can be used to treat larger or more severe hemangiomas. They work by reducing inflammation throughout the body and causing the lesion to shrink.
Interferon: Interferon is a type of protein that can be used to treat severe or disfiguring hemangiomas. It works by reducing the growth of blood vessels and causing the lesion to shrink.
Propranolol: Propranolol is a type of beta-blocker that can be used to treat infantile hemangiomas. It works by reducing the growth of blood vessels and causing the lesion to shrink.
Vincristine: Vincristine is a type of chemotherapy drug that can be used to treat infantile hemangiomas. It works by reducing the growth of blood vessels and causing the lesion to shrink.
Lasers: Lasers, such as the pulsed-dye laser, can be used to treat superficial hemangiomas. They work by destroying the extra blood vessels in the lesion and causing it to shrink.
Surgical Excision: Surgical excision can be used to remove larger or more severe hemangiomas. This involves cutting out the lesion and suturing the wound closed.
Cryotherapy: Cryotherapy involves freezing the lesion with liquid nitrogen to destroy the extra blood vessels and cause it to shrink.
Radiotherapy: Radiotherapy involves using high-energy radiation to destroy the extra blood vessels in the lesion and cause it to shrink.
Embolization: Embolization involves injecting a material into the blood vessels of the lesion to block their flow and cause the lesion to shrink.
Topical Timolol: Topical timolol, a type of beta-blocker, can be used to treat infantile hemangiomas. It works by reducing the growth of blood vessels and causing the lesion to shrink.
Imiquimod: Imiquimod is a type of immune-response modifier that can be used to treat infantile hemangiomas. It works by stimulating the immune system to attack the extra blood vessels in the lesion and cause it to shrink.
Ritonavir: Ritonavir is a type of antiviral drug that can be used to treat infantile hemangiomas. It works by reducing the growth of blood vessels

References